Alyamani, N.; Song, J.; van Katwyk, S.; Thavorn, K.; Renaud, J.; Haddad, A.; MacPherson, M.; Gaudet, M.
Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer. Curr. Oncol. 2021, 28, 2385-2398.
https://doi.org/10.3390/curroncol28040219
AMA Style
Alyamani N, Song J, van Katwyk S, Thavorn K, Renaud J, Haddad A, MacPherson M, Gaudet M.
Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer. Current Oncology. 2021; 28(4):2385-2398.
https://doi.org/10.3390/curroncol28040219
Chicago/Turabian Style
Alyamani, Najlaa, Jiheon Song, Sasha van Katwyk, Kednapa Thavorn, Julie Renaud, Alain Haddad, Miller MacPherson, and Marc Gaudet.
2021. "Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer" Current Oncology 28, no. 4: 2385-2398.
https://doi.org/10.3390/curroncol28040219
APA Style
Alyamani, N., Song, J., van Katwyk, S., Thavorn, K., Renaud, J., Haddad, A., MacPherson, M., & Gaudet, M.
(2021). Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer. Current Oncology, 28(4), 2385-2398.
https://doi.org/10.3390/curroncol28040219